Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes
NCT07509190 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310
Last updated 2026-04-03
Summary
The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes.
For the first part, patients (age 18+) and providers will be asked to complete surveys and participate in focus groups to identify gaps and barriers that limit access to and use of epilepsy surgery.
For piloting the education program, patients (age 18+) at the Cleveland Clinic Epilepsy Monitoring Unit will be randomized to intervention or control. Those in the intervention group, in addition to their usual care, will also receive educational materials on social determinants of health and their influence on surgical rates and epilepsy outcomes. Those in the control group will receive their usual care. Both groups will be asked to fill out surveys and questionnaires at the beginning of their stay, at the end of their stay, and if they elect to have surgery, 12 months after surgery.
Conditions
Interventions
- BEHAVIORAL
-
PEERS Program
This is a video-based intervention complemented by additional education materials, focusing on educating people with epilepsy on the impact of social determinants of health on epilepsy surgery and outcomes
- OTHER
-
Surveys
Participants will receive surveys to assess barriers to accessing epilepsy care
- OTHER
-
Focus group
Participants will participate in focus groups to further identify barriers associated with lack of access and utilization of epilepsy surgery
Sponsors & Collaborators
- collaborator OTHER
-
Anny Reyes
lead OTHER
Principal Investigators
-
Anny Reyes, PhD · The Cleveland Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-18
- Primary Completion
- 2028-12-31
- Completion
- 2029-12-31
Countries
- United States
Study Locations
More Related Trials
-
Cardiovascular Risk Reduction in Epilepsy
NCT05704439 ·Status: WITHDRAWN ·Phase: NA
-
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
NCT01607346 ·Status: TERMINATED ·Phase: PHASE4
-
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT04290975 ·Status: COMPLETED ·Phase: NA
-
Self-management for People with Epilepsy
NCT04705441 ·Status: COMPLETED ·Phase: NA
-
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
NCT05671575 ·Status: UNKNOWN
-
Epilepsy-Associated Stigma
NCT01374204 ·Status: COMPLETED
-
Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)
NCT02925663 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT02625090 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
NCT00228969 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
NYU Epilepsy Self-Management Study
NCT07087821 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy
NCT06175247 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cortical Resections in Drug Resistant Epilepsy
NCT04553354 ·Status: UNKNOWN
-
A Study of GWP42006 in People With Focal Seizures - Part A
NCT02369471 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Women With Epilepsy: Pregnancy Outcomes and Deliveries
NCT01259310 ·Status: COMPLETED
-
Psychosocial Burden of Epilepsy
NCT07449871 ·Status: COMPLETED
-
Surgery as a Treatment for Medically Intractable Epilepsy
NCT01273129 ·Status: RECRUITING
-
GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR
NCT00368069 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
NCT06377930 ·Status: COMPLETED ·Phase: PHASE2
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3